This listing has been expired.
The upcoming DIA China 2024 Meeting will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.
Participants will find an array of diverse perspectives across our over 100 scientific sessions in 15 educational themes, dedicated communication, networking, knowledge sharing opportunities, and a dynamic exhibit hall. By joining us, you will be immersed in conversations with KOLs from all over the world with the same goal – to advance innovation and collaboration that protect people health.
The upcoming DIA China 2024 Meeting will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.
Participants will find an array of diverse perspectives across our over 100 scientific sessions in 15 educational themes, dedicated communication, networking, knowledge sharing opportunities, and a dynamic exhibit hall. By joining us, you will be immersed in conversations with KOLs from all over the world with the same goal – to advance innovation and collaboration that protect people health.
Nate Zhang
VP, Taimei Technology
GM, Clinical Research and Overseas Business
CEO, Taimei Technology US
Nate Zhang
VP, Taimei Technology
GM, Clinical Research and Overseas Business
CEO, Taimei Technology US